Scarica l'app Stockscreener
5.87
1.03%
0.06
Dopo l'orario di chiusura:
5.79
-0.08
-1.36%
Precedente Chiudi:
$5.81
Aprire:
$5.86
Volume 24 ore:
1.10M
Relative Volume:
1.10
Capitalizzazione di mercato:
$763.00M
Reddito:
$204.17M
Utile/perdita netta:
$-74.00M
Rapporto P/E:
-10.16
EPS:
-0.5775
Flusso di cassa netto:
$-12.84M
1 W Prestazione:
+3.89%
1M Prestazione:
+25.16%
6M Prestazione:
+29.58%
1 anno Prestazione:
+60.82%
Intervallo 1D:
$5.75
$5.94
Intervallo di 1 settimana:
$5.53
$5.985
Portata 52W:
$3.31
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
5.87 | 734.41M | 204.17M | -74.00M | -12.84M | -0.5775 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Mostra tutto
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences unveils new cloud platform for seamless lab data analysis - Traders Union
Cytek introduces new end-to-end flow cytometry workflow - Select Science
Cytek Biosciences, Inc. (CTKB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cytek Biosciences Adopts Amended Bylaws Tightening Stockholder Nomination Rules - Minichart
Form 8K Cytek Biosciences Inc For: 29 September By Investing.com - Investing.com Nigeria
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability - Yahoo Finance
Cytek Biosciences launches Cloud Analysis within Cytek Cloud digital ecosystem - Traders Union
Cytek Biosciences launches cloud-based analysis tool - Investing.com
Cytek Biosciences launches cloud-based analysis tool By Investing.com - Investing.com Canada
Cytek Biosciences Expands Cytek Cloud with New Cloud Analysis Tool for End-to-End Flow Cytometry Workflow - Quiver Quantitative
A new tool lets researchers analyze cell data online without rebuilding their work - Stock Titan
Cytek Biosciences stock gains 2.25 percent near its yearly range - AD HOC NEWS
Cytek Biosciences stock trades near recent lows after valuation update - AD HOC NEWS
Cytek Biosciences stock edges higher after recent earnings and analyst interest - AD HOC NEWS
Cytek and Sysmex Europe team up to expand access to advanced clinical flow cytometry - Select Science
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock? - finance.yahoo.com
Transcript : Cytek Biosciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 09 - marketscreener.com
Cytek at Morgan Stanley global healthcare conference: growth broadens - Investing.com
Cytek at Morgan Stanley global healthcare conference: growth broadens By Investing.com - Investing.com UK
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows - marketscreener.com
Sysmex Europe SE And Cytek Biosciences, Inc Collaborate To Expand Access To Advanced Clinical Flow Cytometry - marketscreener.com
Sysmex Europe SE and Cytek Biosciences Announce Strategic Collaboration to Expand Clinical Flow Cytometry Access Across Europe - Quiver Quantitative
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry - Yahoo Finance
CTKB Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesEarnings Decline Risk - dars.gov.et
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing - Yahoo Finance
Cytek Biosciences to Showcase Spectral Flow Cytometry Solutions at ESCCA 2026 and ICCS 2026 - Quiver Quantitative
Cytek Biosciences Showcases Advanced Spectral Flow Cytometry Solutions At Escca and Iccs - marketscreener.com
More than 4,200 peer-reviewed papers cite Cytek’s systems. It will showcase them at two fall meetings. - Stock Titan
Cytek Biosciences (CTKB) officer plans $146K share sale - Stock Titan
Cytek Biosciences stock holds near recent levels as investor conferences approach - AD HOC NEWS
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Owes Beckman Coulter $56 Million at Patent Jury Trial (2) - Bloomberg Law News
Cytek (CTKB) Earnings Report: EPS Clears the Reported Estimate in Latest Trading; Price Reaction: Shares Finish 3.22% Up in the Latest SessionPre-Announcement Alert - vinanet.vn
Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent - Law360
Cytek Biosciences wins on three of four patent claims - Investing.com
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Nigeria
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says - Reuters
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding - marketscreener.com
Cytek products remain available worldwide after jury awards $36M in royalties - Stock Titan
Cytek Biosciences CFO William D. McCombe Executes RSU Vesting and Tax Withholding Transactions - Kalkine Media
Cytek Biosciences Director Glenn P. Muir Converts 3,086 RSUs to Common Stock on August 18, 2026 - Kalkine Media
Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares - Stock Titan
Cytek Biosciences (CTKB) director now holds 28,499 shares - Stock Titan
Cytek Biosciences (CTKB) CTO gets 33,270 shares, surrenders some for taxes - Stock Titan
Cytek (CTKB) Quarterly Figures: EPS Prints Above Forecast in the Latest Session; Stock Move: Shares Finish 0.96% HigherEstimate Dispersion - vinanet.vn
Cytek Biosciences Balances Growth With Profit Pressures - TipRanks
Cytek (CTKB) Q2 2026 Earnings Call Transcript - AOL.com
Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer - Stock Titan
Cytek Biosciences: Recurring Revenue Reaches 35% Of Sales As Installed Base Approaches 4,000 Instruments - Pulse 2.0
Cytek Biosciences launches Aurora Evo system to drive high-throughput research and small particle detection - Traders Union
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):